
The goal of this zzso zzso study of patients treated with zzso was to examine the zzso of zzso diabetes zzso in relation to other factors, including weight gain, zzso zzso age, zzso dose, and treatment with zzso 

Data on age, zzso race, diagnosis, family history of diabetes, and age at zzso initiation were collected from medical records of 82 zzso with schizophrenia or zzso zzso zzso dose, data on use of zzso and laboratory test results were recorded at zzso zzso 

The mean age at the time of zzso initiation of the 82 patients was zzso years; zzso of the patients were women, and zzso were zzso The mean baseline weight was zzso zzso and the mean body mass index was zzso zzso Thirty patients zzso were diagnosed with diabetes during the zzso zzso Weight gain, use of zzso and total daily dose of zzso were not significant risk factors for developing diabetes zzso Patients experienced significant weight gain that continued until approximately month 46 from initiation of zzso There was a zzso increase in total serum cholesterol and a significant increase in serum zzso zzso 

The results support the hypotheses that patients treated with zzso experience significant weight gain and zzso abnormalities and appear to be at increased risk for developing zzso 

